Pyridoxine deficiency in children treated with isoniazid.
Isoniazid-induced deficiency of pyridoxine (vitamin B6) is reportedly not uncommon in adults but rare in children. In the present study, 38 children had serum levels of pyridoxine tested while receiving therapy with isoniazid. A biologic assay using the protozoan Tetrahymena thermophila determined pyridoxine status after 2 to 18 months of therapy with isoniazid. Five children (13 percent) were deficient. None had definitive clinical symptoms or signs consistent with pyridoxine deficiency. Three had normal nerve conduction velocity. Children receiving isoniazid in dosages greater than 10 mg/kg/day had a higher incidence of deficiency. Present recommendations for withholding pyridoxine prophylaxis from children receiving isoniazid therapy must be reconsidered in light of these findings, particularly in those children who are debilitated or have a poor nutritional history with a known pyridoxine deficit prior to therapy with isoniazid.
D002648:Child; D002664:Child Nutritional Physiological Phenomena; D002675:Child, Preschool; D004576:Electromyography; D005260:Female; D006801:Humans; D007223:Infant; D007538:Isoniazid / Q000009:adverse effects*; D008297:Male; D011736:Pyridoxine / Q000097:blood; D012640:Seizures / Q000188:drug therapy; D014388:Tuberculosis, Lymph Node / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D026681:Vitamin B 6 Deficiency / Q000139:chemically induced* / Q000503:physiopathology
D011736:Pyridoxine; D007538:Isoniazid